Skip Nav Destination
Issues
1 August 2011
-
Cover Image
Cover Image
The search for biomarkers of cancer has focused on the tumor cells themselves. Pitteri et al. using an unbiased and in depth proteomic analysis of plasma from a model of Her2/neu driven breast cancer have identified the signaling between the tumor cells and microenvironment as a primary source of biomarkers. Shown are tumor cells embedded within extensive extracellular collagen matrix stained with trichrome blue. For details, see the article by Pitteri and colleagues on page 5090 of this issue. - PDF Icon PDF LinkTable of Contents
ISSN 0008-5472
EISSN 1538-7445
Issue Sections
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Breaking Advances
Reviews
Priority Reports
Clinical Studies
Integrated Systems and Technologies
Tumor Microenvironment–Derived Proteins Dominate the Plasma Proteome Response during Breast Cancer Induction and Progression
Sharon J. Pitteri; Karen S. Kelly-Spratt; Kay E. Gurley; Jacob Kennedy; Tina Busald Buson; Alice Chin; Hong Wang; Qing Zhang; Chee-Hong Wong; Lewis A. Chodosh; Peter S. Nelson; Samir M. Hanash; Christopher J. Kemp
Microenvironment and Immunology
Myeloid-Derived Suppressor Cell Inhibition of the IFN Response in Tumor-Bearing Mice
Bethany L. Mundy-Bosse; Gregory B. Lesinski; Alena C. Jaime-Ramirez; Kristen Benninger; Mahmood Khan; Periannan Kuppusamy; Kristan Guenterberg; Sri Vidya Kondadasula; Abhik Ray Chaudhury; Krista M. La Perle; Melanie Kreiner; Gregory Young; Denis C. Guttridge; William E. Carson, III
PD-1/PD-L1 Interactions Contribute to Functional T-Cell Impairment in Patients Who Relapse with Cancer After Allogeneic Stem Cell Transplantation
Wieger J. Norde; Frans Maas; Willemijn Hobo; Alan Korman; Michael Quigley; Michel G.D. Kester; Konnie Hebeda; J.H. Frederik Falkenburg; Nicolaas Schaap; Theo M. de Witte; Robbert van der Voort; Harry Dolstra
Systemic Cancer Therapy with a Small Molecule Agonist of Toll-like Receptor 7 Can Be Improved by Circumventing TLR Tolerance
Carole Bourquin; Christian Hotz; Daniel Noerenberg; Andreas Voelkl; Simon Heidegger; Laurin C. Roetzer; Bettina Storch; Nadja Sandholzer; Cornelia Wurzenberger; David Anz; Stefan Endres
Molecular and Cellular Pathobiology
18F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers
Nicolaos Palaskas; Steven M. Larson; Nikolaus Schultz; Evangelia Komisopoulou; Justin Wong; Dan Rohle; Carl Campos; Nicolas Yannuzzi; Joseph R. Osborne; Irina Linkov; Edward R. Kastenhuber; Richard Taschereau; Seema B. Plaisier; Chris Tran; Adriana Heguy; Hong Wu; Chris Sander; Michael E. Phelps; Cameron Brennan; Elisa Port; Jason T. Huse; Thomas G. Graeber; Ingo K. Mellinghoff
Prevention and Epidemiology
Therapeutics, Targets, and Chemical Biology
Exosome Targeting of Tumor Antigens Expressed by Cancer Vaccines Can Improve Antigen Immunogenicity and Therapeutic Efficacy
Ryan B. Rountree; Stefanie J. Mandl; James M. Nachtwey; Katie Dalpozzo; Lisa Do; John R. Lombardo; Peter L. Schoonmaker; Kay Brinkmann; Ulrike Dirmeier; Reiner Laus; Alain Delcayre
A Drug Resistance Screen Using a Selective MET Inhibitor Reveals a Spectrum of Mutations That Partially Overlap with Activating Mutations Found in Cancer Patients
Ralph Tiedt; Elisa Degenkolbe; Pascal Furet; Brent A. Appleton; Sabrina Wagner; Joseph Schoepfer; Emily Buck; David A. Ruddy; John E. Monahan; Michael D. Jones; Jutta Blank; Dorothea Haasen; Peter Drueckes; Markus Wartmann; Clive McCarthy; William R. Sellers; Francesco Hofmann
Overcoming Hypoxia-Induced Apoptotic Resistance through Combinatorial Inhibition of GSK-3β and CDK1
Patrick A. Mayes; Nathan G. Dolloff; Colin J. Daniel; J. Judy Liu; Lori S. Hart; Kageaki Kuribayashi; Joshua E. Allen; David I.H. Jee; Jay F. Dorsey; Yingqiu Y. Liu; David T. Dicker; J. Martin Brown; Emma E. Furth; Peter S. Klein; Rosalie C. Sears; Wafik S. El-Deiry
Tumor and Stem Cell Biology
Letters to the Editor
Corrections
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.